HKT-500 in the Treatment of Adult Patients With Ankle Sprain

Completed · Phase 3 · Has a placebo group

Conditions studied: Ankle Sprain

In brief

The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.

Key facts

Study ID
NCT00927641
Run by
Hisamitsu Pharmaceutical Co., Inc.
People needed
240
Starts
2009-07-01
Expected to finish
2010-11-01
Last updated by the study team
2015-06-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.